Increased oxidative stress with decreased SIRT3 protein and activity levels have been reported during NAFLD and in HFD rodent models of obesity2,3,7,9,11,26,30. This evidence concerns the gene SIRT3 and metabolic dysfunction-associated steatotic liver disease.